Shared Decision-Making: AFib 2gether Mobile App

Not Applicable

Completed

Brief Summary: Shared Decision-Making: AFib 2gether™ is a research study that focuses on a mobile application developed by Pfizer, Inc with consultation from Dr McManus' called AFib 2gether™. Through this app, patients can determine their risk of stroke due to atrial fibrillation and prioritize questions and concerns for discussion with their cardiology provider.

Recruitment & Eligibility

Inclusion Criteria

Providers:

Caring for at least 3 patients aged 18 years and older
Have at least 3 patients with International Classification of Diseases tenth revision (ICD-10) diagnostic code consistent with atrial fibrillation (AF) or atrial flutter
Have at least 3 patients with a CHA2DS2-VASc stroke risk score of 2 or more
Have at least 3 patients who are not on anticoagulation
Have at least 3 patients with upcoming appointments within the next 4 months

Patients:

Age 18+
Preferred language is English
Atrial fibrillation diagnosis
Chads vasc score 2 or higher
Not on anticoagulants
No watchman or atrial appendage closure
Had an ambulatory care center (ACC) cardiology appointment in the past 12 months
Future appointment in the next 4 months with the same provider

Exclusion Criteria

Providers:

Providers who do not care for at least 3 patients aged 18 years and older
Have patients that do not have an ICD-10 diagnostic code consistent with AF or atrial flutter
Does not have patients with a CHA2DS2-VASc stroke risk score of 2 or more
Their patients are on anticoagulation
Their 3 patients do not have an upcoming visit within the next 4 months

Patients:

Under the age of 18; patients
No ICD-10 diagnostic code consistent with AF or atrial flutter
Did not have a visit with a cardiovascular medicine specialist in the previous one year
Patients with a CHA2DS2-VASc score less than 2
Currently prescribed an anticoagulant
No upcoming cardiology visit in the next 3 months
Has a WATCHMAN device or left atrial appendage closure surgery
On hospice or for whom life expectancy is less than six months and patients
Bleeding episode or fall with injury in the last four weeks
Does not speak English
Prisoner

Primary Outcome Measures

Name	Time	Method
Patient MARS Scores	Immediately after visit	Patients evaluated the perceived usefulness of the AFib 2gether mobile application by taking the Mobile App Rating Scale (MARS) questionnaire. This evaluated 3 domains: functionality, aesthetics, and a star-based question. These scores are rated 1-5 with 5 being the highest (best) score.

Secondary Outcome Measures

Name	Time	Method
Provider MARS Scores	Immediately after visit.	Providers were asked to navigate the app features and rate their overall opinion of the mobile app by answering questions using the Mobile App Rating Scale (MARS). This scale evaluates 3 domains: functionality, aesthetics, and a star-based rating question. These scores are rated 1-5 with 5 being the highest (best) score.
Reason Why the Patient Was Not on AC Prior to Their Appointment	Immediately after visit	This was an evaluation of why the patient was not on an anticoagulant (AC) prior to their appointment.
Afib 2gether Accuracy Assessment	Immediately after visit.	The provider was asked to review the patients stroke risk score on the AFib 2gether app and compare to provider clinical assessment for accuracy. The number of accurate scores were recorded. Ten of the original thirteen providers completed this assessment.